CJC-1295 with DAC is a Growth Hormone Releasing Hormone (GHRH) analog engineered with Drug Affinity Complex (DAC) technology. This modification significantly extends the peptide’s half-life, leading to a longer duration of growth hormone release compared to the No DAC version. Because of this, researchers often investigate it in contexts where sustained elevation of growth hormone may be advantageous.
Potential areas of research include:
-
Muscle growth and lean body mass development
-
Fat metabolism and body composition improvement
-
Accelerated tissue repair and recovery
-
Anti-aging and longevity studies
-
Improved sleep and overall vitality
-
Cognitive and mood support
Disclaimer: For Research Use Only – Not for Human Use.




